CClinicalTrials.gg
CompletedNCT00999310Updated Jun 2, 2015

Neuropsychologic, Neuroradiologic, Endocrinologic, and Genetic Aspects of Klinefelter Syndrome

An observational study in Klinefelter Syndrome, sponsored by University of Aarhus. Completed at 1 site in Denmark. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-06-02.

Sponsored by University of Aarhus · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
146
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The purpose of this study is to investigate the following:

  1. Whether Klinefelter Syndrome is associated with altered total and regional brain volumes and altered brain activity.
  2. The influence of genetic factors and testosterone treatment on the neuropsychological phenotype, total and regional brain volumes and brain activity in men with Klinefelter syndrome.
Read the detailed description

Klinefelter syndrome (KS) is the most common sex-chromosome disorder in men with a prevalence of 1 in 660 men. Men with the syndrome have an additional X-chromosome. The syndrome is associated with cognitive and behavioral dysfunction and also with hypogonadism. Magnetic resonance imaging have pointed to different volumetric alterations in several brain structures. Several genetic factors involving the X-chromosome have been suggested to influence the neuropsychological phenotype in men with KS.

The aim of this study is to investigate the following: 1.Whether KS is associated with altered total and regional brain volumes and altered brain activity. 2.Whether genetic factors influence the neuropsychological phenotype, total and regional brain volumes, and brain activity in men with KS. 3.Whether testosterone treatment improves cognitive skills and change brain activity in men with KS.

Participants are divided in 5 groups: 1. 50 men with KS who receive testosterone treatment. 2. 50 men KS who do not receive testosterone treatment. 3. 100 age-matched control men.4. 50 age-matched control women are included as a control group for X-chromosome inactivation pattern. 5. Parents of KS subjects in group 1 and 2 are included to determine the parental origin of the supernumerary X-chromosome. Methods include a 3-hour battery of standardized neuropsychological tests to cover a broad range of cognitive domains and to assess major domains of personality. We use magnetic resonance imaging to measure total and regional brain volumes and functional magnetic resonance imaging to measure brain activity while subjects are performing a attention-demanding cognitive task. The genetic testing includes the parental origin of the supernumerary X-chromosome, the pattern of X-chromosome inactivation, androgen receptor (AR) CAGn repeat length, and gene expression profile of brain-expressed genes.

02

Conditions studied

  • Klinefelter Syndrome

Keywords

  • Klinefelter syndrome
  • Neuropsychology
  • Neuroradiology
  • Genetics
03

In context

Klinefelter Syndrome

43 studies on the registry are indexed under Klinefelter Syndrome; 15 are open to participants now.

This study's enrollment of 146 is below the median of 300 across 24 observational studies indexed under Klinefelter Syndrome.

Browse Klinefelter Syndrome studies →

Lead sponsor

University of Aarhus is the lead sponsor of 1,274 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients with Klinefelter syndrome are recruited from endocrine and fertility clinics.

The control groups are recruited by advertising for healthy volunteers at the University of Aarhus and at the Blood Bank at the Aarhus University Hospital.

Inclusion criteria

  • age between 18 and 60 years
  • verified KS karyotype (KS patients)

Exclusion criteria

Exclusion Criteria:

  • present or past neurological diseases
  • present or past head trauma
  • contraindication to perform MR scans(Claustrophobia,Magnetic or electric foreign bodies - including cardiac pacemakers, magnetic cerebrovascular clips and electric non-removable appliances dosing medicine)
  • extreme adiposity (BMI > 35 kg/m2)
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
146 participants (actual)
Biospecimen retention
Samples with dna

Groups and cohorts

  • Klinefelter syndrome
  • Control men
  • Control women
  • parents of Klinefelter groupe
06

Study locations

1 site
  • Medical Department M, Endocrinology and Diabetes, and Medical Research Laboratories, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44
    Aarhus, 8000, Denmark
07

References and documents

Publications

  • Chang S, Skakkebaek A, Trolle C, Bojesen A, Hertz JM, Cohen A, Hougaard DM, Wallentin M, Pedersen AD, Ostergaard JR, Gravholt CH. Anthropometry in Klinefelter syndrome--multifactorial influences due to CAG length, testosterone treatment and possibly intrauterine hypogonadism. J Clin Endocrinol Metab. 2015 Mar;100(3):E508-17. doi: 10.1210/jc.2014-2834. Epub 2014 Dec 16. PubMed 25514102 ↗
  • Skakkebaek A, Bojesen A, Kristensen MK, Cohen A, Hougaard DM, Hertz JM, Fedder J, Laurberg P, Wallentin M, Ostergaard JR, Pedersen AD, Gravholt CH. Neuropsychology and brain morphology in Klinefelter syndrome - the impact of genetics. Andrology. 2014 Jul;2(4):632-40. doi: 10.1111/j.2047-2927.2014.00229.x. Epub 2014 May 28. PubMed 24865607 ↗
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 2, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00999310
Lead sponsor
University of Aarhus
Collaborators
Aarhus University Hospital
Responsible party
Sponsor
First posted
Oct 21, 2009
Start date
Nov 2009
Primary completion
Apr 2012
Completion
Jun 2013
Last update
Jun 2, 2015

Study contacts

Claus H Gravholt, MD, DMSCI
principal investigator · Medical Department M, Endocrinology and Diabetes, and Medical Research Laboratories, Clinical Institute, Aarhus University Hospital, Aarhus, Denmark
Anne S Jensen, MD
principal investigator · University of Aarhus

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion